Haig Aghajanian
Company: Capstan Therapeutics
Job title: Co-Founder, Vice President & Head of Research
Seminars:
Panel Discussion: Allogeneic vs Autologous vs In Vivo: How will these Co-Exist? 11:30 am
Comparing advantages and limitations of each approach to determine optimal applications Discussing key challenges faced by each approach to enlighten considerations in development Unearthing novel methods to advance efficacies in both approaches Read more
day: Cell Therapy Fundamentals Day
In Vivo Engineering of Immune Cells with mRNA LNP 1:30 pm
Specificity and efficiency of delivering mRNA to T-cells in vivo In vivo production of functional CAR-T cells In vivo CAR-T cell functionality in oncology and autoimmune settings Read more
day: Cell Therapy Fundamentals Day